PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

Title: Initial Experience from the INSPIRE DUCHENNE Phase I/II Study of SGT-003 Microdystrophin Gene Therapy for Duchenne ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally ...

Muscular Dystrophy Association event brings scientists, clinicians and other experts together with patient communities to ...

The Psychedelic Science conference, coming to Denver this summer, plans to bring U.S. legislators, scientists, authors, mycologists and more together to discuss the new frontier of psychedelic ...

Bringing together eminent scientists, researchers, and industry leaders, the Longevity India Conference 2025 – Rise for ...

Del-zota produced statistically significant increases in exon skipping and dystrophin levels in EXPLORE44, a Phase 1/2 study in patients with DMD44 (oral presentation) Aravindhan Veerapandiyan, MD ...

The 10th Chandigarh Social Science Congress concluded at Panjab University after a series of academic sessions featuring ...

Eight members of Youngstown State University’s Data Science Club attended the Data Science Salon conference in Texas.

Clinical & Scientific Conference, being held March 16-19, 2025 in Dallas, TX. The oral presentations feature data from the ongoing CONNECT1-EDO51 clinical trial in Duchenne muscular dystrophy (DMD ...

Including two conference players of the year, these Wisconsin high-school alumni earned all-conference accolades in college.

The University of Pittsburgh and Carnegie Mellon University won’t host a conference of science journalists and other science writers that was set for October after the Trump administration’s proposed ...